Cargando…

Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer

PURPOSE: DEAD box protein 3 (DDX3) is an RNA helicase with oncogenic properties that shuttles between the cytoplasm and nucleus. The majority of DDX3 is found in the cytoplasm, but a subset of tumors has distinct nuclear DDX3 localization of yet unknown biological significance. This study aimed to e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heerma van Voss, Marise R, Vesuna, Farhad, Bol, Guus M, Meeldijk, Jan, Raman, Ana, Offerhaus, G Johan, Buerger, Horst, Patel, Arvind H, van der Wall, Elsken, van Diest, Paul J, Raman, Venu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522823/ https://www.ncbi.nlm.nih.gov/pubmed/28761359 http://dx.doi.org/10.2147/OTT.S140639

Ejemplares similares

Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer
por: van Voss, Marise R. Heerma, et al.
Publicado: (2015)

Role of DDX3 in the pathogenesis of inflammatory bowel disease
por: Tantravedi, Saritha, et al.
Publicado: (2017)

Targeting RNA helicase DDX3 in stem cell maintenance and teratoma formation
por: Kerr, Candace L., et al.
Publicado: (2019)

Expression of the RNA Helicase DDX3 and the Hypoxia Response in Breast Cancer
por: Bol, Guus M., et al.
Publicado: (2013)

The prognostic effect of DDX3 upregulation in distant breast cancer metastases
por: Heerma van Voss, Marise R., et al.
Publicado: (2016)

Targeting DDX3 with a small molecule inhibitor for lung cancer therapy
por: Bol, Guus M, et al.
Publicado: (2015)

Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach
por: Heerma van Voss, Marise R., et al.
Publicado: (2018)

Expression of DDX3 Is Directly Modulated by Hypoxia Inducible Factor-1 Alpha in Breast Epithelial Cells
por: Botlagunta, Mahendran, et al.
Publicado: (2011)

Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment
por: Heerma van Voss, Marise R., et al.
Publicado: (2017)

DDX3, a potential target for cancer treatment
por: Bol, Guus Martinus, et al.
Publicado: (2015)

NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3
por: Xie, Min, et al.
Publicado: (2015)

Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33
por: Tantravedi, Saritha, et al.
Publicado: (2018)

Cytoplasmic DDX3 as prognosticator in male breast cancer
por: van der Pol, Carmen C., et al.
Publicado: (2021)

Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls
por: van Voss, Marise R Heerma, et al.
Publicado: (2010)

Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer
por: Heerma van Voss, Marise R., et al.
Publicado: (2011)

miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers
por: Vos, Shoko, et al.
Publicado: (2015)

Genomic pathways modulated by Twist in breast cancer
por: Vesuna, Farhad, et al.
Publicado: (2017)

RK-33, a small molecule inhibitor of host RNA helicase DDX3, suppresses multiple variants of SARS-CoV-2
por: Vesuna, Farhad, et al.
Publicado: (2022)

Divergent organ-specific isogenic metastatic cell lines identified using multi-omics exhibit differential drug sensitivity
por: Winnard, Paul T., et al.
Publicado: (2020)

Twist contributes to hormone resistance in breast cancer by down-regulating estrogen receptor alpha
por: Vesuna, Farhad, et al.
Publicado: (2011)

p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast
por: Ercan, Cigdem, et al.
Publicado: (2012)

No Amplifications of Hypoxia-Inducible Factor-1α Gene in Invasive Breast Cancer: A Tissue Microarray Study
por: Vleugel, Marije M., et al.
Publicado: (2004)

Expression Pattern of a Homeotic Gene, HOXA5, in Normal Breast and in Breast Tumors
por: Henderson, Gregory S., et al.
Publicado: (2006)

RNA Helicase DDX3 Regulates RAD51 Localization and DNA Damage Repair in Ewing Sarcoma
por: Randolph, Matthew E., et al.
Publicado: (2023)

Venezuelan equine encephalitis virus non-structural protein 3 (nsP3) interacts with RNA helicases DDX1 and DDX3 in infected cells
por: Amaya, Moushimi, et al.
Publicado: (2016)

Chromosome 17 copy number changes in male breast cancer
por: Lacle, Miangela M., et al.
Publicado: (2015)

Organ-specific isogenic metastatic breast cancer cell lines exhibit distinct Raman spectral signatures and metabolomes
por: Winnard, Paul T., et al.
Publicado: (2017)

Pathology of hereditary breast cancer
por: van der Groep, Petra, et al.
Publicado: (2011)

Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast
por: Kuijper, Arno, et al.
Publicado: (2005)

Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1α expression
por: Hyseni, Agon, et al.
Publicado: (2011)

Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer
por: Moelans, Cathy B., et al.
Publicado: (2018)

Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer
por: van der Groep, Petra, et al.
Publicado: (2007)

Prognostic Value of Mitotic Index and Bcl2 Expression in Male Breast Cancer
por: Lacle, Miangela M., et al.
Publicado: (2013)

Differential Expression of Growth Factor Receptors and Membrane-Bound Tumor Markers for Imaging in Male and Female Breast Cancer
por: Vermeulen, Jeroen F., et al.
Publicado: (2013)

Expression of Connective Tissue Growth Factor in Male Breast Cancer: Clinicopathologic Correlations and Prognostic Value
por: Lacle, Miangela M., et al.
Publicado: (2015)

Comparison of Different Promoter Methylation Assays in Breast Cancer
por: Suijkerbuijk, Karijn P. M., et al.
Publicado: (2010)

Conditional Inactivation of HIF-1 Using Intrabodies
por: Groot, Arjan J., et al.
Publicado: (2008)

Hormone- and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the Netherlands
por: van Dooijeweert, Carmen, et al.
Publicado: (2019)

Grading variation in 2,934 patients with ductal carcinoma in situ of the breast: the effect of laboratory- and pathologist-specific feedback reports
por: van Dooijeweert, Carmen, et al.
Publicado: (2020)

Application of Nipple Aspirate Fluid miRNA Profiles for Early Breast Cancer Detection and Management
por: Moelans, Cathy B, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v8scl1f9e8ilkbjjuca9up72v8